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Abstract
Background: Nitrous oxide (N2O) provides sedation for procedures that result in constant low-
intensity pain. How long do individuals remain sleepy after receiving N2O? We hypothesized that
drug effects would be apparent for an hour or more.
Methods: This was a randomized, double blind controlled study. On three separate occasions,
volunteers (N = 12) received 100% oxygen or 20% or 40% N2O for 30 min. Dependent measures
included the multiple sleep latency test (MSLT), a Drug Effects/Liking questionnaire, visual analogue
scales, and five psychomotor tests. Repeated measures analysis of variance was performed with
drug and time as factors.
Results: During inhalation, drug effects were apparent based on the questionnaire, visual analogue
scales, and psychomotor tests. Three hours after inhaling 100% oxygen or 20% N2O, subjects were
sleepier than if they breathed 40% N2O. No other drug effects were apparent 1 hour after
inhalation ceased. Patients did not demonstrate increased sleepiness after N2O inhalation.
Conclusion: We found no evidence for increased sleepiness greater than 1 hour after N2O
inhalation. Our study suggests that long-term effects of N2O are not significant.
Background
Nitrous oxide (N2O) is useful for procedures that result in
constant low-intensity pain. Its use has been described in
the dentist's office, in the management of orthopedic pro-
cedures in the emergency room, for colonoscopy, and for
dermatologic procedures [1-7]. Specifically, it is used to
control pain and provide sedation.
If patients continue to be sleepy after N2O inhalation,
should they have an escort home and be told not to drive
for 24 hr afterwards? In most operating rooms, after any
type of sedation, patients are told not to drive or operate
heavy machinery for 24 hours. In general dental offices,
patients are not told to refrain for 24 hours from driving
or operating heavy machinery. Few studies have examined
how performance is affected after N2O. Subjective and
psychomotor function tests have shown that effects last
less than 1 hour after N2O cessation.
Polysomnographic measures of sedation can detect effects
of sedatives not detected by subjective assessment and
performance measures [8]. In that study, for example, the
multiple sleep latency test (MSLT) demonstrated sleepi-
ness up to 4 hours after injection of one combination of
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anesthetic drugs, and in some subjects, sleepiness contin-
ued up to 8 hours afterwards; psychomotor function was
impaired only at 2 hours after injection of the drug
combination.
We hypothesized that sleepiness could be measured for 1
hour or more after N2O cessation. We sought to establish
a basis for decisions concerning discharge requirements
and instructions for patients after N2O for sedation.
Methods
Experimental design
This was a randomized, double blind, controlled study.
The experiment consisted of one practice session and
three study sessions. Volunteers were always admitted on
the same day of the week for each of the days of drug inha-
lation. Volunteers were studied after inhaling 100% oxy-
gen, 20% N2O or 40% N2O. The research technicians and
subjects were unaware of the dose of N2O administered
(double-blind), and concentrations were randomized.
The anesthesiologist administering the agent was aware of
the dose but had minimal verbal contact with the subjects
during the session.
Subjects
Our Institutional Review Board approved this study. Can-
didates who met screening criteria (healthy, non-smok-
ing, age 21–35 years, and within 30% of ideal body
weight) and who had normal sleeping habits were sched-
uled for a screening interview [9]. Informed written con-
sent was obtained from subjects before the first session.
During a practice session, subjects were exposed to the dif-
ferent tests in the battery to gain familiarity with them.
Ten men and five women volunteered for the study. On
each day of testing, urine pregnancy tests were performed
to ensure that female subjects were not pregnant. Subjects
were asked to avoid depressants including ethanol (con-
firmed by measuring exhaled ethanol) and stimulants for
24 hours before study sessions. Subjects were paid for
their participation upon study completion.
Experimental sessions
In the first or pre-test day of study, subjects slept in Gen-
eral Clinical Research Center (GCRC) overnight. Their
sleep was monitored with an electroencephalogram
(EEG) or an activity monitor. The following day, sleep
latency measured by the multiple sleep latency test
(MSLT) and psychomotor performance were tabulated at
1000, 1200, 1400, and 1600 hours. Subjects were admit-
ted to the study if average sleep latency was ≥10 min and
they had no onsets of rapid eye movement (REM) sleep,
which is indicative of narcolepsy. One volunteer was
excluded from the study because sleep latency was too
short; two others declined to participate after the first ses-
sion for personal reasons. Twelve subjects went on to
complete the study.
During the three study sessions, subjects again slept over-
night in the GCRC. They were again monitored to ensure
8 hours in bed and adequate sleep efficiency (sleep time >
75% of time in bed). They were in bed by 2230 and were
awakened at 0630. At that time, all female subjects had a
urine test for pregnancy to verify a negative result. Subjects
fasted overnight. At 0700 ECG electrodes, a blood pres-
sure cuff, and oxygen saturation monitor were applied to
subjects seated in a chair; ECG and oxygen saturation were
measured continuously and blood pressure measure-
ments were made every 5 min during the inhalation
period.
Subjects initially inhaled oxygen through a clear anaesthe-
sia facial mask affixed to the face via attached rubber
straps that went around the head. Baseline mood and psy-
chomotor tests were performed. Subjects were told at that
time that they were not breathing a drug. Subjects were
then told that for 30 min they would be breathing air that
may or may not contain drug (100% oxygen, 20% N2O or
40% N2O). At 10 and 20 min after the start of the inhala-
tion period, subjects completed the mood tests and a sub-
set of the psychomotor tests. At the end of the 30-min
inhalation period, the mask was removed. At one, 3, 5,
and 7 hours after inhalation ended, subjects completed
the sleep latency test and tests of mood, and psychomotor
performance. The technician who gave the tests was not
aware of the drug administered. When no tests were
scheduled, subjects were free to engage in sedentary recre-
ational activities, but studying and sleep were not permit-
ted. Room temperature was kept constant. Subjects were
allowed to eat a small snack after the Hour-1 test, and
lunch after the Hour-3 test.
Dependent measures
The primary dependent variable was daytime sleepiness.
Daytime sleepiness was measured with the sleep latency
test. Measures of subjective effects, and psychomotor per-
formance were also performed. All tests but the sleep
latency test took 5–6 min to complete, and the order of
the tests remained the same throughout the experiment.
During the time that drug was inhaled, only a subset of
tests was administered; these took about 3 min to
complete.
Multiple sleep latency test (MSLT)
The procedure for performing the MSLT has been
described in detail [8]. At 1, 3, 5, and 7 hours after cessa-
tion of drug inhalation, subjects were instructed to lie
down on a bed in a dark, quiet room to try to fall asleep.
Sleep latency was scored in minutes to the first epoch ofBMC Anesthesiology 2004, 4 http://www.biomedcentral.com/1471-2253/4/5
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non-wake [10]. Sleep latency was considered the primary
dependent variable.
Subjective effects
To assess subjective effects, we used two questionnaires.
The Drug Effects/Liking questionnaire (locally developed)
with two items assessed the extent to which subjects cur-
rently felt a drug effect on a scale of 1 to 5 (1 = "I feel no
effect at all"; to 5 = "I feel a very strong effect"). The extent
to which subjects liked the drug effect was assessed on a
100-mm line (0 = dislike a lot, 50 = neutral, 100 = like a
lot). The Drug Effects/Liking questionnaire was filled out
before drug inhalation, 10 min and 20 min into the inha-
lation, and 1, 3, 5, and 7 hours after inhalation had
ceased.
The Visual Analogue Scale (VAS) consisted of twenty-one
100-mm lines, each labelled with one of the following
adjectives (locally selected): anxious, coasting, confused,
difficulty concentrating, down, drunk, elated, feel bad,
feel good, floating, high ('drug high'), light-headed, nau-
seous, pleasant bodily sensations, pleasant thoughts,
sedated, sleepy, stimulated, tingling, unpleasant bodily
sensations, unpleasant thoughts. Subjects were instructed
to place a mark on each line indicating how they felt now,
ranging from "not at all" to "extremely." The VAS was
filled out before drug inhalation, 10 and 20 min into the
inhalation, and 1, 3, 5, and 7 hours after inhalation had
ceased.
Psychomotor performance
Subjects completed five psychomotor tests: auditory reac-
tion time [11], visual reaction time [11], divided attention
[11], the digit symbol substitution test (DSST) [12], and
the Maddox Wing test [13]. All of the psychomotor tests
were performed before and 1, 3, 5, and 7 hours after drug
inhalation. The DSST was also performed 10 and 20 min
into the inhalation period.
Data analysis
Repeated measures analysis of variance was performed
with drug and time as factors. F-values were considered
significant for p < 0.05 with adjustment of within-factors
degrees of freedom (Huynh-Feldt) to protect against vio-
lations of symmetry. Post-hoc testing compared the differ-
ent drug concentrations at corresponding time points in
the session using a priori comparisons with Bonferroni
adjustments.
Results
The mean age (±SD) was 25.3 ± 3.3 years. Mean height
was 176.5 ± 10.7 cm. Mean weight was 69.9 ± 13.3 kg.
While breathing 20 or 40% N2O, there was a clear drug
effect. A significant interaction between drug concentra-
tion and time was observed on the drug effect rating (p <
0.0001) (figure 1). Post-hoc testing revealed significant
concentration effects during drug inhalation (0% vs. 20%
N2O p < 0.0002; 20% vs. 40% N2O p < 0.0002). Signifi-
cant interaction between drug concentration and time was
observed on the ratings for "difficulty concentrating" (p <
0.025) and "tingling" (p < 0.05). Significant differences
on post-hoc testing during the inhalation period between
0% and 20% N2O were seen with the rating "tingling" (p
< 0.05) and between 20% and 40% N2O with the ratings
"anxious" (p < 0.02), and "high" (p < 0.05). A significant
interaction between drug concentration and time was
observed on the DSST test. Post-hoc testing revealed sig-
nificant concentration effects during drug inhalation (0%
vs. 20% N2O p < 0.02; 20% vs. 40% N2O p < 0.0002).
After inhalation ceased, residual sleepiness was measured
after 100% oxygen and 20% N2O, but not after 40% N2O.
With the MSLT, there was a significant time effect (p <
0.05) and a significant drug time interaction after 100%
oxygen (p < 0.05). When the volunteers breathed 100%
oxygen, they were sleepier 3 hours after inhalation than 1
hour after inhalation (p < 0.025). After breathing 20%
N2O, volunteers took longer to fall asleep at 1 hour than
at 3 hours (p < 0.025) (Figure 2).
Self-reported drug effect Figure 1
Self-reported drug effect. Self-reported strength of drug 
effect of 0%, 20% or 40% N2O is shown as a function of time. 
The solid bars indicate the average response time; whiskers 
indicate SD. PRE refers to the measure taken at baseline; IA 
refers to the averaged value during inhalation; 1, 3, 5, and 7 
refer to hours after inhalation ceased. An asterisk represents 
a significant difference between a value at a given concentra-
tion at a particular time during inhalation and the lower adja-
cent concentration at the same time point.BMC Anesthesiology 2004, 4 http://www.biomedcentral.com/1471-2253/4/5
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After inhalation ceased, no tests of psychomotor perform-
ance or subjective effects were significant. No significant
differences were seen with auditory, visual, or divided
attention reaction times, incorrect responses, or the Mad-
dox Wing test. Figure 3 demonstrates how the subjective
tests showed significant change during inhalation but not
at any time after inhalation ceased.
Discussion
We hypothesized that after 30 min of N2O inhalation,
drug effects, particularly our primary variable sleep
latency, could be measured at least 1 hour afterwards and
perhaps longer. If our hypothesis were true, it would sup-
port the (hospital) practice of not allowing patients to
drive home after inhaling nitrous oxide. Proscribing cer-
tain activities (e.g., driving, operating heavy machinery, or
cooking for the remainder of the day) after N2O inhala-
tion would also apply. Our hypothesis, though, was dis-
proved. During N2O, inhalation subjects had mood and
psychomotor effects. Depending on the concentration,
subjects felt a drug effect and were anxious; had difficulty
concentrating; felt high, light-headed, and tingling; and
showed impairment on the DSST. One hour after inhala-
tion stopped, these effects were not significant.
Despite no evidence of sleepiness 1 hour after N2O inha-
lation, 3 hours after drug inhalation subjects were sleepier
than at 1 hour after inhalation, particularly when no or
20% N2O was inhaled. This result may be attributed to the
fact that sleep propensity follows temperature rhythms
and has a moderate nadir in the middle of the day [14].
Why we did not find this effect after 40% N2O is unclear.
Rebound insomnia is known to occur after depressants
such as alcohol and benzodiazepines [15].
We did not measure end-expired concentrations of N2O,
measurements that are not reliable when a facemask is
used. Our anaesthesia machine was calibrated, although
room air may have leaked in through the facemask during
inhalation. Yet, our results are similar to those of others
who have studied the effects of inhaled N2O. In one study,
22 min after subjects inhaled 30% N2O, psychomotor
performance had returned to baseline [16]. In another
study, when 40% N2O was inhaled for 30 min, self-
reported strength of drug effect was significant and sub-
jects felt drunk, spaced out, and high [17]. By 60 min after
drug inhalation had ceased the drug effect disappeared. In
a previous study, we found that, although psychomotor
function tests indicated no effect 2 hours after drug injec-
tion, shorter sleep latency times were significant for at
least 4 hours after injection of midazolam and fentanyl for
sedation [8]. Although we hypothesized similar results
with N2O, the results were not similar.
In many areas of healthcare, 40% N2O has been used with
a great degree of safety. 20% N2O is not typically used. We
included the lower N2O concentration in our study to see
if there was a linear dose response.
Many procedures in ambulatory care facilities are per-
formed on patients who have concomitant disease,
chronic obstructive pulmonary disease and sleep apnoea.
Our results may not be applicable to these patients and
may not be generalized because other variables were not
considered. Patients may experience pain because of a
procedure, and our volunteers did not. Nitrous oxide
inhalation may be needed for longer than 30 minutes for
procedures. Nitrous oxide might also be used with other
drugs. Shift workers may be tired during the day and this
sleepiness might interact with the effects of the drugs.
Similarly, individuals might not sleep well prior to their
procedure, and we only studied individuals who slept
normally prior to receiving N2O.
In many studies, N2O performance, memory, or mood
with N2O have been measured during N2O inhalation,
not after. When painful transcutaneous electrical stimula-
tion and somatosensory evoked potentials were used to
examine the time course of function for up to 35 minutes
after 50% N2O inhalation, impairment lasted as long as
35 minutes afterwards and was as great as impairment
during inhalation [18]. In another study in which a driv-
ing simulator was used, errors increased 15 minutes after
exposure to 50% and 70% N2O [19]. Mood changes
Multiple sleep latency test Figure 2
Multiple sleep latency test. Effects of time (1, 3, 5, and 7 
hours after inhalation ceased) as a function of N2O concen-
tration for multiple sleep latency test is illustrated. The solid 
bars indicate the average response time; whiskers indicate 
SD. An asterisk represents a significant difference between a 
value at a given concentration and time after inhalation 
ceased and the lower adjacent time point at the same 
concentration.BMC Anesthesiology 2004, 4 http://www.biomedcentral.com/1471-2253/4/5
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(mental and physical sedation) were evident up to 15
minutes after 25% N2O inhalation, although no impair-
ment was found during the recovery period by objective
tests. According to a series of tests that take about five min-
utes to perform, memory returned to baseline after 20
minutes, but subjective effects of N2O extended for up to
8 hours [20]. Others who studied the possible interaction
of N2O with ethanol, found a drug effect for at least one
hour after 30% N2O inhalation ceased [21]. Performance
effects in other studies lasted only five minutes [16,22].
Conclusions
In conclusion, we found no evidence for increased sleepi-
ness 1 hour or greater after N2O inhalation. Our study
suggests that long-term effects of N2O, particularly
sleepiness, are not significant. Patients should be advised
to avoid activities shortly after N2O inhalation that might
Other drug effects Figure 3
Other drug effects. Effects of 0%, 20% or 40% N2O as a function of time for having difficulty concentrating (figure 3a), feeling 
high (figure 3b), and tingling (figure 3c) are illustrated. The solid bars indicate the average response time; whiskers indicate SD. 
PRE refers to the measure taken at baseline; IA refers to the averaged value during inhalation; 1, 3, 5, and 7 refer to hours after 
inhalation ceased. An asterisk represents a significant difference between a value at a given concentration at a particular time 
during inhalation and the lower adjacent concentration at the same time point.Publish with BioMed Central    and   every 
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harm themselves or others. After one hour, though, there
is no evidence for abstaining from normal activities. The
data presented in this study only applies to N2O given
alone. No inference regarding N2O with additional seda-
tives can be made regarding post-administration impair-
ment. Further study is warranted in patients with
concomitant disease or in those who have inhaled N2O
for longer periods.
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